The effects of risedronate on canine cancellous bone remodeling: Three‐dimensional kinetic reconstruction of the remodeling site

Journal of Bone and Mineral Research

Volumn 10, Issue 2, 1995, Pages 211-221

  Boyce, R W ^a   Paddock, C L ^a   Gleason, J R ^b   Sletsema, W K ^a   Eriksen, E F ^c  

^a PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

^b SYRACUSE UNIVERSITY   (United States)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

RISEDRONIC ACID;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCELLOUS BONE; CONTROLLED STUDY; DOG; DOSE RESPONSE; DOSE TIME EFFECT RELATION; FEMALE; GROWTH REGULATION; MORPHOMETRICS; NONHUMAN; ORAL DRUG ADMINISTRATION; OSTEOBLAST; OSTEOLYSIS; THREE DIMENSIONAL IMAGING;

ADMINISTRATION, ORAL; ANIMAL; BONE DENSITY; BONE DEVELOPMENT; BONE DISEASES, METABOLIC; BONE REMODELING; BONE RESORPTION; CALCIUM CHANNEL BLOCKERS; CELL WALL; COMPARATIVE STUDY; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ETIDRONIC ACID; FEMALE; HUMAN; ILIUM; KINETICS; MODELS, BIOLOGICAL; MODELS, THEORETICAL; OSTEOBLASTS; OSTEOPOROSIS, POSTMENOPAUSAL;

EID: 0028909290     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.5650100207     Document Type: Article

References (31)

1. Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo
2. Inhibition of bone resorption by bisphosphonates: Interactions between bisphosphonates, osteoclasts and bone
3. 2MDP) and ethane‐1‐hydroxy‐1,1‐diphospho‐nate (EHDP) on growth and modeling of the rat tibia
4. 2MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats
5. Different schedules of administration of 3‐amino‐1‐hydroxy‐propylidine‐1,1‐bisphos‐phonate induce different changes in pig bone remodeling
6. Inhibition of bone matrix apposition by 3‐amino‐1‐hydroxypropylidine‐1,1‐bisphosphonate (AHPrBP) in the mouse
7. Focal osteomalacia due to low dose diphosphonate therapy in Pagets disease
8. Normal and pathological remodeling of human trabecular bone: Three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease
9. Preparation of calcified tissues for light microscopy
10. Effect of intermittent cyclical etidronate on bone mass and fracture rate in women with postmenopausal osteoporosis
11. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis
12. Migration and phenotypic transformation of osteoclast precursors into mature osteoclasts: the effect of a bisphosphonate
13. Inhibition of osteoclast‐like cell formation by bisphosphonates in long term cultures of human bone marrow
14. Two modes of action of bisphosphonates on osteoclastic resorption in vitro
15. 2MBP‐coated bone
16. Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy
17. Bisphosphonates act on rat bone resorption through the mechanism of osteoblasts
18. The effects of etidronate on trabecular bone remodeling in postmenopausal spinal osteoporosis: A randomized study comparing intermittent treatment and an ADFR regime
19. A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis
20. Reconstruction of the resorptive site in iliac trabecular bone: A kinetic model for bone resorption in 20 normal individuals
21. Kinetics of trabecular bone resorption and formation in hypothyroidism: evidence for a positive balance per remodeling cycle
22. Changes in bone histomorphometry after long term treatment with intermittent cyclic etidronate for postmenopausal osteoporosis
23. The bisphosphonate APD stimulates inhibited osteoblasts thus preventing the development of inflammation mediated osteopenia (IMO)
24. Low concentrations of APD (3‐amino‐1‐hydroxypropylidine‐1,1‐diphosphonic acid) affect both osteoclast recruitment and human osteoclast‐like cells in vitro
25. Rapid intracellular degradation of newly synthesized collagen by bone cells: Effects of dichloromethylene bisphosphonate
26. Menopausal changes in calcium balance performance
27. Bone remodeling: Relationship to the amount and structure of bone and the pathogenesis and prevention of fracture
28. Implications of architecture for the pathogenesis and prevention of vertebral fracture
29. Trabecular bone resorption depth decreases with age: Differences between normal males and females
30. Use of bisphosphonates in the prevention of bone loss and fractures